Pharma & medtech · US
2 stories in 24h · Business, Markets · Clear all filters
-
Pharma & medtech · Brazil
MarketWatchUSSource paywall
Midterm elections provided the hyperscalers with the excuse they needed to cut back on spending, says Jefferies strategistIf the AI capex narrative is losing momentum then Jefferies strategist Chris Wood can recommen some sectors …
-
Markets · China
South China Morning PostCNSource paywall
Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drugChina has approved US pharmaceutical giant Eli Lilly’s weight-loss pill orforglipron, making it the country’s first available oral…